IL307715A - Perfusion methods for growing a mammalian cell culture - Google Patents

Perfusion methods for growing a mammalian cell culture

Info

Publication number
IL307715A
IL307715A IL307715A IL30771523A IL307715A IL 307715 A IL307715 A IL 307715A IL 307715 A IL307715 A IL 307715A IL 30771523 A IL30771523 A IL 30771523A IL 307715 A IL307715 A IL 307715A
Authority
IL
Israel
Prior art keywords
methods
mammalian cell
perfusion culturing
perfusion
culturing
Prior art date
Application number
IL307715A
Other languages
English (en)
Hebrew (he)
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of IL307715A publication Critical patent/IL307715A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL307715A 2021-04-14 2022-04-14 Perfusion methods for growing a mammalian cell culture IL307715A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163174900P 2021-04-14 2021-04-14
PCT/US2022/024781 WO2022221511A1 (en) 2021-04-14 2022-04-14 Methods of perfusion culturing a mammalian cell

Publications (1)

Publication Number Publication Date
IL307715A true IL307715A (en) 2023-12-01

Family

ID=81585645

Family Applications (1)

Application Number Title Priority Date Filing Date
IL307715A IL307715A (en) 2021-04-14 2022-04-14 Perfusion methods for growing a mammalian cell culture

Country Status (12)

Country Link
US (1) US20220333054A1 (https=)
EP (1) EP4323500A1 (https=)
JP (1) JP2024514327A (https=)
KR (1) KR20230170728A (https=)
CN (1) CN117255851A (https=)
AU (1) AU2022258569A1 (https=)
BR (1) BR112023021192A2 (https=)
CA (1) CA3215302A1 (https=)
IL (1) IL307715A (https=)
MX (1) MX2023012193A (https=)
TW (1) TW202305109A (https=)
WO (1) WO2022221511A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202001034PA (en) 2014-12-22 2020-04-29 Genzyme Corp Methods of culturing a mammalian cell
WO2021097281A1 (en) 2019-11-15 2021-05-20 Lonza Ltd Process and system for producing an inoculum
EP4628570A1 (en) * 2024-04-03 2025-10-08 Aposcience AG Method for cultivating mammalian cells

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856179A (en) * 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5721121A (en) * 1995-06-06 1998-02-24 Genentech, Inc. Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
AU2002316230A1 (en) * 2001-06-13 2002-12-23 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
AU2002348151A1 (en) * 2001-11-05 2003-05-19 Genvec, Inc. Viral vector production methods and compositions
CA2557046A1 (en) * 2004-03-05 2005-10-13 John Crowley Process for cell culturing by continuous perfusion and alternating tangential flow
AU2007294731B2 (en) * 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
US8911964B2 (en) * 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CN102112595B (zh) * 2008-08-06 2014-11-26 普莱克斯技术有限公司 用于控制哺乳动物细胞培养过程的系统和方法
WO2010120514A2 (en) 2009-03-31 2010-10-21 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
AU2014226126B2 (en) * 2013-03-08 2019-02-14 Genzyme Corporation Continuous purification of therapeutic proteins
TWI743024B (zh) * 2014-06-06 2021-10-21 美商健臻公司 灌注培養方法及其用途
SG10202001034PA (en) * 2014-12-22 2020-04-29 Genzyme Corp Methods of culturing a mammalian cell
SG11201909087PA (en) * 2017-03-31 2019-10-30 Boehringer Ingelheim Int Perfusion medium
JP7495483B2 (ja) * 2019-09-27 2024-06-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 濃縮灌流培地

Also Published As

Publication number Publication date
CA3215302A1 (en) 2022-10-20
KR20230170728A (ko) 2023-12-19
JP2024514327A (ja) 2024-04-01
US20220333054A1 (en) 2022-10-20
TW202305109A (zh) 2023-02-01
WO2022221511A1 (en) 2022-10-20
MX2023012193A (es) 2023-10-25
AU2022258569A1 (en) 2023-11-30
EP4323500A1 (en) 2024-02-21
BR112023021192A2 (pt) 2023-12-19
CN117255851A (zh) 2023-12-19

Similar Documents

Publication Publication Date Title
IL307715A (en) Perfusion methods for growing a mammalian cell culture
Ma et al. Strategies for optimizing the production of proteins and peptides with multiple disulfide bonds
Yazawa et al. Recent advances in chemoenzymatic peptide syntheses
Aguilar et al. Crystal structure of the β-glycosidase from the hyperthermophilic archeon Sulfolobus solfataricus: resilience as a key factor in thermostability
Yeboah et al. Elastin‐like polypeptides: A strategic fusion partner for biologics
Tian et al. Tubulin subunits exist in an activated conformational state generated and maintained by protein cofactors
US10030221B2 (en) Microtiter plates for controlled release of culture components to cell cultures
Nasr et al. Covalently circularized nanodiscs; challenges and applications
Zawada et al. Cell-free technologies for biopharmaceutical research and production
WO2009091912A3 (en) Improved mammalian expression vectors and uses thereof
BR112012011980A2 (pt) Métodos de produzir células transformadas de yarrowia lipolytica e proteínas-alvocompreendendo n-glicanos, células transformadas de yarrowia lipolytica e suas culturas, bem como composição compreendendo glicoproteínas
Xu et al. O-mannosylation: The other glycan player of ER quality control
IL276211B2 (en) HU14.18K322A monoclonal antibody production process
CN116925240A (zh) 一种重组胶原蛋白及其表达方法和应用
Liu et al. Plug-and-play functionalization of protein–polymer conjugates for tunable catalysis enabled by genetically encoded “click” chemistry
JP2005523681A5 (https=)
Mertz et al. Increased protein encapsulation in polymersomes with hydrophobic membrane anchoring peptides in a scalable process
CN103421834A (zh) 一种利用枯草芽孢杆菌表达外源蛋白的方法
Stamsås et al. CHiC, a new tandem affinity tag for the protein purification toolbox
CN106046164A (zh) 抗CTLA‑4的纳米抗体Nb36及其制备方法与应用
CN119350505A (zh) 蛋白质纯化方法
Son Regulation of Tissue Regeneration by Immune Microenvironment–Fibroblast Interactions
Merzlyak et al. Engineering phage materials with desired peptide display: rational design sustained through natural selection
McCormick et al. Expression, isolation, and purification of soluble and insoluble biotinylated proteins for nerve tissue regeneration
TW201805298A (zh) 製造重組蛋白質之方法